Drug Injuries
FDA Approves Nucala for Younger Patients
Young patients with severe eosinophilic asthma can now being accessing treatment with Nucala, manufactured by GlaxoSmithKline. In September 2013, the Food and Drug Administration approved the maintenance treatment for children between the ages of 6 …
Zantac Recall Lawsuit
If you took Zantac or a generic version of the over-the-counter medication and were diagnosed with cancer, you should speak to a Zantac lawyer immediately.
Hepatitis C Drugs Warning Lawsuit
Hepatitis C patients were warned by the FDA that a relatively successful medication may actually worsen liver damage commonly associated with HCV.
Complera Lawsuit
Our TDF lawyers provide lawsuit information for HIV and HBC patients who were injured by Complera.
Atripla Lawsuit
Atripla is a combination HIV medication that contains efavirenz, emtricitabine, and tenofovir disoproxil fumarate (TDF). It is part of a group of TDF Lawsuits our law firm is actively taking new cases on. In 2001, …
Stribild Lawsuit
Stribild is a combination HIV medication that contains elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil (TDF). It is part of a group of TDF Lawsuits our law firm is actively taking new cases on. Stribild and other …
TDF Lawsuit
Have you or someone you love experienced kidney damage, bone loss, or other severe side effects from TDF medications? You are not alone. Read more to find out the dangers of Viread, Truvada, Atripla, Stribild, and Complera.
Truvada Lawsuit
If you’re reading this article, chances are you’re already familiar with PReP. It’s one of the most widely prescribed anti-HIV medications on the global market. But there are risks to taking PReP (also known as …
Amiodarone Lawsuit
The side effects of Amiodarone can actually worsen an arrhythmia. Drug companies have marketed it as a first-line medication, contrary to what the FDA approved it for.
Uloric Lawsuit
The popular gout medication Uloric recently received a boxed warning from the U.S. Food & Drug Administration (FDA) due to an increased risk of heart-related death. The U.S. Food and Drug Administration announced a medication …